Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APLNR | P35414 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8313692 | 0.62 | KMT2A (0.36) | APLNRHTT | |
| SCHEMBL10716500 | 0.60 | APLNR (0.32) | APLNRHTT | |
| SCHEMBL468398 | 0.59 | TSHR (0.35) | CYP1A2CYP2D6CYP2C19 | |
| SCHEMBL25955125 | 0.58 | APLNR (0.50) | APLNRCYP1A2CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL10640937 | 0.57 | — | — | |
| SCHEMBL23115271 | 0.56 | POLB (0.30) | — | |
| SCHEMBL1487444 | 0.56 | APLNR (0.33) | APLNRHTTCYP1A2CYP2C19 | |
| SCHEMBL4321495 | 0.56 | HTT (0.52) | APLNRHTTCYP1A2CYP2D6CYP2C19 | |
| SCHEMBL8632263 | 0.56 | APLNR (0.33) | APLNRHTTCYP1A2CYP2C19 | |
| SCHEMBL14506000 | 0.56 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117202938-A | Variant Fc domains and uses thereof | 奇达拉治疗公司 | 2023-12-08 | — | — | CN | disclosed |
| CN-114980933-A | Compositions and methods for treating viral infections | 奇达拉治疗公司 | 2022-08-30 | — | — | CN | disclosed |
| CN-114728937-A | Compositions and methods for treating respiratory syncytial virus | 奇达拉治疗公司 | 2022-07-08 | — | — | CN | disclosed |
| CN-114599389-A | Variant FC domains and uses thereof | 奇达拉治疗公司 | 2022-06-07 | — | — | CN | disclosed |
| CN-114401731-A | Compositions and methods for treating human immunodeficiency virus | 奇达拉治疗公司 | 2022-04-26 | — | — | CN | disclosed |
| CN-114390929-A | Compositions and methods for treating respiratory syncytial virus | 奇达拉治疗公司 | 2022-04-22 | — | — | CN | disclosed |
| CN-114302741-A | Compositions and methods for treating autoimmune disorders | 密执安大学评议会 | 2022-04-08 | — | — | CN | disclosed |
| CN-113194983-A | Compositions and methods for treating viral infections | 奇达拉治疗公司 | 2021-07-30 | — | — | CN | disclosed |
| CN-104230900-A | Antiviral compounds | GILEAD SCIENCES INC | 2014-12-24 | — | — | CN | disclosed |
| CN-104211689-A | Antiviral compounds | GILEAD SCIENCES INC | 2014-12-17 | — | — | CN | disclosed |
| EP-2398492-A1 | CYTOTOXIC CONJUGATES HAVING NEUROPEPTIDE Y RECEPTOR BINDING COMPOUND | IPSEN PHARMA S.A.S. (FR) | 2011-12-28 | — | — | EP | disclosed |
| WO-2010096175-A1 | CYTOTOXIC CONJUGATES HAVING NEUROPEPTIDE Y RECEPTOR BINDING COMPOUND | IPSEN PHARMA S.A.S. (FR) | 2010-08-26 | — | — | WO | disclosed |
| EP-1881982-A1 | IMIDAZOLONE PHENYLALANINE DERIVATIVES AS VLA-4 ANTAGONISTS | Elan Pharmaceuticals Inc. (US) | 2008-01-30 | — | — | EP | disclosed |
| CN-1913889-A | Compositions comprising HIV protease inhibitor and cytochrome P450 enzyme activity inhibitor | PFIZER (US) | 2007-02-14 | — | — | CN | disclosed |
| WO-2006127584-A1 | IMIDAZOLONE PHENYLALANINE DERIVATIVES AS VLA-4 ANTAGONISTS | ELAN PHARMACEUTICALS, INC. (US) | 2006-11-30 | — | — | WO | disclosed |
| CN-1550496-A | Acetylenic alpha-amino acid-based sulfamide hydroxamic acid TACE inhibitors | ���Ͽع�����˾ | 2004-12-01 | — | — | CN | disclosed |
| CN-1345308-A | Acetylenic alpha-amino acid based sulfonamide hydroxamic acid TACE inhibitors | AMERICAN CYANAMID CO (US) | 2002-04-17 | — | — | CN | disclosed |
| EP-0668875-A4 | CLOT DIRECTED ANTICOAGULANT, PROCESS FOR MAKING SAME AND METHODS OF USE. | AGEN LTD (AU) | 1999-05-26 | — | — | EP | disclosed |
| EP-0668875-A1 | CLOT DIRECTED ANTICOAGULANT, PROCESS FOR MAKING SAME AND METHODS OF USE | AGEN LIMITED (AU) | 1995-08-30 | — | — | EP | disclosed |
| WO-1994009034-A1 | CLOT DIRECTED ANTICOAGULANT, PROCESS FOR MAKING SAME AND METHODS OF USE | AGEN LIMITED (AU) | 1994-04-28 | — | — | WO | disclosed |